Related Articles
New Sleep Medication Approved: Daridorexant (Quviviq)
On Jan 10, 2022, FDA has approved this new medication for treatment of adults with insomnia: Quviviq (daridorexant). This FDA approval is based on the…
LYBALVIâ„¢: New Medication FDA Approved for Schizophrenia & Bipolar Disorder
June 01, 2021 Today FDA approved LYBALVI for the treatment of: Schizophrenia in adults Bipolar I disorder in adults Acute treatment of manic or mixed…
Antidepressant Induced Excessive Sweating
Antidepressant-induced excessive sweating (ADIES) is reported in more than 20% of patients taking antidepressants. For this reason, the knowledge on how to identify and manage…
Navigating the Complex Terrain of Drug Interactions: Hydroxychloroquine & Psychiatric Medications
In the realm of modern medicine, managing drug interactions is crucial for ensuring patient safety and efficacy of treatments. Among these interactions, those between hydroxychloroquine…
Ulipristal Acetate for PMDD Treatment?
Share This Post Share on facebook Share on linkedin Share on twitter Share on email Close to 70-90 % of reproductive age women are known…
Responses